Bicycle Therapeutics

Bicycle Therapeutics is a clinical-stage pharmaceutical company developing precision-guided medicines using its proprietary bicyclic peptide technology, known as Bicycle molecules. Its work focuses primarily on oncology, including targeted drug conjugates, radioconjugates and immune-cell agonists designed to deliver therapeutic payloads directly to diseased tissue while limiting impact on healthy cells. The company researches and advances its own pipeline of cancer therapies and also collaborates with pharmaceutical partners to apply its platform across other hard-to-treat diseases. Operating in the biotechnology and biopharmaceutical industry, Bicycle Therapeutics combines drug discovery, translational research and clinical development to create novel treatments for areas of high unmet medical need.